Please login to the form below

Not currently logged in
Email:
Password:

Dr Colin Goddard appointed chairman at Mission Therapeutics

Will take up the role at the Cambridge, UK firm in January

Mission Therapeutics Colin GoddardMission Therapeutics has appointed Dr Colin Goddard as its non-executive chairman, a role he will take up on January 1.

He first joined the Cambridge, UK-based drug discovery and development company as a non-executive director in July 2015.

Meanwhile, Mission Therapeutics' current chairman Dr Michael Moore will continue to sit on the firm's board and move into the role of deputy chairman.

Dr Moore said: “On behalf of the board, it gives me great pleasure to welcome Colin in his new role as the company progresses to the next phase of its evolution. I look forward to continuing to work with him and the board of directors as, together with an outstanding management team we continue to shape the company's strategy. 

 “Colin's timely accession extents the business reach of Mission commensurate with the significant advances in R&D.”

Prior to joining Mission, Dr Goddard had served as chief executive officer of OSI Pharmaceuticals since 1998, after joining the firm as a research scientist in 1989.

After OSI's acquisition by Astellas in June 2010 for $4bn Dr Goddard served as chairman and CEO of US-based biotech company BlinkBio.

12th December 2016

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...